Chinese Contract Drugmaker Pharmaron Raises $589m In HK Listing

Business - Published date: Friday November 22, 2019.

Chinese contract drugmaker Pharmaron Beijing Co. raised HK$4.6 billion ($589 million) after pricing its Hong Kong listi... Read more